4-(2-Methylpropyl)cyclohexan-1-amine | 38793-00-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 4-(2-Methylpropyl)cyclohexan-1-amine
• CAS: 38793-00-9
• 化学式: C₁₀H₂₁N
• 分子量: 155.283
• InChiKey: URIVDFHRALOZMH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  聚合甲醛 、 4-(2-Methylpropyl)cyclohexan-1-amine 在 甲酸 、 水 作用下， 生成 (4-异丁基-环庚基)-二甲基-胺
  参考文献：
  名称：

  314.Dioscorea hispida，dennstedt的一种生物碱。第三部分 霍夫曼降解的进一步研究

  摘要：

  DOI：

  10.1039/jr9560001577

文献信息

• Methods and compositions of novel triazine compounds
  申请人：Timmer T. Richard

  公开号：US20070099874A1

  公开（公告）日：2007-05-03

  The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

  本发明涉及用于治疗由炎症反应引起的病理生理状态的化合物的方法和组合物。特别地，本发明涉及抑制或阻断糖化蛋白诱导内皮细胞信号相关炎症反应的化合物。本发明涉及抑制平滑肌增殖的化合物。特别地，本发明涉及通过调节HSPG（如Perlecan）来抑制平滑肌细胞增殖的化合物。本发明进一步涉及使用化合物治疗由平滑肌增殖所特征的血管闭塞性疾病，例如再狭窄和动脉粥样硬化。
• IMIDAZO[1,2-B]PYRIDAZINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
  申请人：Xu Yong

  公开号：US20120058997A1

  公开（公告）日：2012-03-08

  The present invention provides protein kinase inhibitors comprising imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine compounds of the following structure (I) and (II): or a stereoisomer, prodrug or pharmaceutically acceptable salt thereof, wherein R, R 1 , R 2 and X are as defined herein. Compositions and methods for using the same in the treatment of cancer and other Pim kinase-associated conditions are also disclosed.

  本发明提供了蛋白激酶抑制剂，包括以下结构（I）和（II）的咪唑[1,2-b]吡啶和吡唑[1,5-a]嘧啶化合物或其立体异构体、前药或药物可接受的盐，其中R、R1、R2和X如本文所定义。还公开了将其用于治疗癌症和其他Pim激酶相关疾病的组合物和方法。
• PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
  申请人：Roughton Andrew Laird

  公开号：US20110218189A1

  公开（公告）日：2011-09-08

  The present invention relates to a pyrrolo[2,3-d]pyrimidin-2-yl-amine derivative according to formula (I) wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising one or more of said pyrrolo[2,3-d]pyrimidine-2-ylamine derivatives and to their use in therapy, for instance in the treatment of PKCθ mediated disorders.

  本发明涉及一种按照公式（I）定义的吡咯并[2,3-d]嘧啶-2-基氨基衍生物，其中变量如规范中所定义，或其药学上可接受的盐或溶剂。本发明还涉及一种含有一种或多种所述吡咯并[2,3-d]嘧啶-2-基氨基衍生物的制药组合物，以及它们在治疗中的使用，例如在PKCθ介导的疾病治疗中的使用。
• Crystalline polypropylene resin composition and amide compounds
  申请人：NEW JAPAN CHEMICAL CO.,LTD.

  公开号：EP0557721A2

  公开（公告）日：1993-09-01

  Disclosed are a crystalline polypropylene resin composition comprising a crystalline polyproplylene resin and a β-nucleating agent, and a method of increasing the proportion of β-form crystals in a crystalline polypropylene resin molding comprising molding the composition, the β-nucleating agent being a diamide compound.

  本发明公开了一种结晶聚丙烯树脂组合物，该组合物由结晶聚丙烯树脂和 β 成核剂组成；还公开了一种增加结晶聚丙烯树脂模塑中 β 形晶体比例的方法，该方法包括模塑该组合物，β 成核剂为二酰胺化合物。
• Porous stretched article of polypropylene-based resin and process for its preparation
  申请人：NEW JAPAN CHEMICAL CO.,LTD.

  公开号：EP0632095A2

  公开（公告）日：1995-01-04

  Disclosed are a process for producing a porous stretched article of β-crystalline polypropylene-based resin, the process comprising the steps of crystallizing a melt of a polypropylene-based resin composition at a temperature of 15 to 140°C to form a solidified product containing β-form crystals and stretching the resulting solidified product at a temprature which is higher than 20 °C but lower than the melting point of the β-form crystals in said solidified product, the polypropylene-based resin composition comprising a polypropylene-based resin and 0.0001 to 5 parts by weight, per 100 parts by weight of the polypropylene-based resin, of at least one specific amide compound; and a porous stretched article produced by the process.

  本发明公开了一种用β-结晶聚丙烯基树脂生产多孔拉伸制品的工艺，该工艺包括以下步骤：在15至140℃的温度下使聚丙烯基树脂组合物的熔体结晶，形成含有β-结晶的固化物，并在高于20℃但低于所述固化物中β-结晶的熔点的温度下拉伸所得固化物，所述聚丙烯基树脂组合物包括聚丙烯基树脂和0.0001至5份（按每100份聚丙烯基树脂的重量计）的至少一种特定酰胺化合物；以及由该工艺生产的多孔拉伸制品。